Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/20969

TDMS Study 91005-07 Pathology Tables

NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05
Route: GAVAGE                                                                                                     Time: 10:00:58

                                                         FINAL #1 RATS




       Facility:  Southern Research Institute

       Chemical CAS #:  7220-79-3

       Lock Date:  09/05/03

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      6            4            9           11                                     
    Moribund Sacrifice                                 9           13            5            3                                     
    Dosing Accident                                                                           1                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                35           32           34           35                                     
    Natural Death                                                                2                                                  
  Other                                                             1                                                               
                                                                                                                                    
  Animals Examined Microscopically                    50           49           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (49)         (50)         (50)                                   
      Perforation                                                                1 (2%)                                             
   Intestine Large, Colon                             (50)         (48)         (49)         (48)                                   
      Cyst                                                                                    1 (2%)                                
   Intestine Small, Duodenum                          (49)         (48)         (49)         (48)                                   
      Ectopic Tissue                                                                          1 (2%)                                
   Liver                                              (50)         (49)         (50)         (50)                                   
      Basophilic Focus                                37 (74%)     34 (69%)     38 (76%)     40 (80%)                               
      Clear Cell Focus                                 8 (16%)      5 (10%)      9 (18%)      8 (16%)                               
      Degeneration, Cystic                             1 (2%)       1 (2%)                    1 (2%)                                
      Eosinophilic Focus                               3 (6%)       2 (4%)                                                          
      Hepatodiaphragmatic Nodule                       7 (14%)      4 (8%)       7 (14%)      4 (8%)                                
      Inflammation, Chronic                            6 (12%)      4 (8%)       4 (8%)       5 (10%)                               
      Necrosis, Focal                                  1 (2%)                    1 (2%)                                             
      Bile Duct, Hyperplasia                           7 (14%)      5 (10%)      6 (12%)      2 (4%)                                
      Centrilobular, Necrosis                          2 (4%)                    1 (2%)                                             
      Hepatocyte, Vacuolization Cytoplasmic            4 (8%)       4 (8%)                                                          
   Mesentery                                          (17)         (14)         (12)         (8)                                    
      Accessory Spleen                                              1 (7%)                                                          
      Fat, Necrosis                                   17 (100%)    14 (100%)    11 (92%)      8 (100%)                              
   Oral Mucosa                                        (2)                                    (1)                                    
      Pharyngeal, Cyst                                 1 (50%)                                1 (100%)                              
   Pancreas                                           (49)         (48)         (48)         (49)                                   
      Atrophy                                         26 (53%)     20 (42%)     23 (48%)     23 (47%)                               
      Inflammation                                                  1 (2%)                                                          
      Acinus, Hyperplasia, Focal                       3 (6%)       1 (2%)       2 (4%)       1 (2%)                                
   Salivary Glands                                    (50)         (49)         (50)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation                                                               1 (2%)                                             
   Stomach, Forestomach                               (50)         (49)         (49)         (49)                                   
      Edema                                            2 (4%)       3 (6%)       1 (2%)                                             
      Erosion                                                                                 1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)                                 2 (4%)                                
      Ulcer                                            4 (8%)       3 (6%)       1 (2%)       1 (2%)                                
      Epithelium, Hyperplasia                          2 (4%)       2 (4%)       2 (4%)       3 (6%)                                
   Stomach, Glandular                                 (50)         (49)         (48)         (49)                                   
      Edema                                            2 (4%)       1 (2%)       1 (2%)                                             
      Erosion                                          2 (4%)       2 (4%)                                                          
      Ulcer                                            2 (4%)       1 (2%)       1 (2%)                                             
   Tongue                                             (1)          (1)          (1)          (1)                                    
      Cyst                                                          1 (100%)                                                        
      Hyperplasia                                      1 (100%)                               1 (100%)                              
      Inflammation                                                  1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (49)         (50)         (50)                                   
      Cardiomyopathy                                  36 (72%)     41 (84%)     36 (72%)     32 (64%)                               
      Thrombosis                                                    1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (49)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                9 (18%)      7 (14%)      8 (16%)     12 (24%)                               
      Degeneration, Fatty                             11 (22%)     13 (27%)     13 (26%)      8 (16%)                               
      Hyperplasia, Focal                               5 (10%)      8 (16%)      8 (16%)      6 (12%)                               
      Hypertrophy, Focal                              12 (24%)     11 (22%)     13 (26%)      7 (14%)                               
      Necrosis                                         2 (4%)       1 (2%)                                                          
   Adrenal Medulla                                    (50)         (49)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)       2 (4%)       1 (2%)                                             
   Islets, Pancreatic                                 (49)         (48)         (48)         (49)                                   
      Hyperplasia                                     13 (27%)     15 (31%)     15 (31%)     15 (31%)                               
      Metaplasia, Hepatocyte                           2 (4%)                                                                       
   Pituitary Gland                                    (50)         (49)         (50)         (50)                                   
      Pars Distalis, Angiectasis                      28 (56%)     27 (55%)     29 (58%)     21 (42%)                               
      Pars Distalis, Cyst                             21 (42%)     19 (39%)     16 (32%)     23 (46%)                               
      Pars Distalis, Hyperplasia, Focal                5 (10%)      8 (16%)      6 (12%)      6 (12%)                               
      Pars Intermedia, Cyst                            1 (2%)                                                                       
   Thyroid Gland                                      (50)         (49)         (50)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Ultimobranchial Cyst                             2 (4%)                    1 (2%)                                             
      C-Cell, Hyperplasia                             10 (20%)     11 (22%)      7 (14%)      5 (10%)                               
      Follicle, Cyst                                   2 (4%)       1 (2%)       2 (4%)       4 (8%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (50)         (48)         (50)         (50)                                   
      Cyst                                             4 (8%)       7 (15%)      4 (8%)       6 (12%)                               
      Inflammation, Chronic                            1 (2%)       5 (10%)      2 (4%)       4 (8%)                                
   Ovary                                              (50)         (49)         (50)         (50)                                   
      Cyst                                            11 (22%)      4 (8%)       9 (18%)     10 (20%)                               
   Uterus                                             (50)         (49)         (50)         (50)                                   
      Cyst                                             1 (2%)       3 (6%)       2 (4%)       3 (6%)                                
      Hemorrhage                                       1 (2%)                                 1 (2%)                                
      Hydrometra                                       1 (2%)       4 (8%)       2 (4%)       1 (2%)                                
      Cervix, Cyst                                     1 (2%)                                                                       
      Endometrium, Hyperplasia, Cystic                 4 (8%)       1 (2%)                    2 (4%)                                
   Vagina                                                                       (1)                                                 
      Cyst                                                                       1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (49)         (50)         (50)                                   
      Hyperplasia                                      8 (16%)      8 (16%)      9 (18%)      6 (12%)                               
   Lymph Node                                         (15)         (8)          (11)         (3)                                    
      Mediastinal, Congestion                          1 (7%)                                                                       
      Mediastinal, Hyperplasia, Lymphoid               5 (33%)      7 (88%)      8 (73%)      2 (67%)                               
      Pancreatic, Hyperplasia, Lymphoid                1 (7%)                    1 (9%)       1 (33%)                               
   Lymph Node, Mesenteric                             (49)         (49)         (50)         (50)                                   
      Hyperplasia, Lymphoid                                         1 (2%)       1 (2%)                                             
   Spleen                                             (49)         (48)         (49)         (49)                                   
      Fibrosis                                         2 (4%)                                                                       
      Hematopoietic Cell Proliferation                 3 (6%)       5 (10%)      7 (14%)      8 (16%)                               
      Necrosis                                         1 (2%)                                                                       
      Capsule, Fibrosis                                8 (16%)     17 (35%)     12 (24%)     20 (41%)                               
      Lymphoid Follicle, Atrophy                                                 1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Lymphoid Follicle, Hyperplasia                   1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (49)         (50)         (50)                                   
      Cyst                                                                       2 (4%)       1 (2%)                                
      Galactocele                                                   1 (2%)       1 (2%)       1 (2%)                                
      Hyperplasia                                     18 (36%)     19 (39%)      9 (18%)      7 (14%)                               
      Hyperplasia, Atypical                            3 (6%)       3 (6%)       1 (2%)                                             
      Duct, Dilatation                                31 (62%)     28 (57%)     29 (58%)     24 (48%)                               
      Duct, Hyperplasia                                2 (4%)                                 1 (2%)                                
   Skin                                               (50)         (49)         (50)         (50)                                   
      Inflammation, Chronic                                         2 (4%)                                                          
      Inflammation, Chronic Active                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (49)         (50)         (50)                                   
      Inflammation                                                               1 (2%)                                             
      Cranium, Osteopetrosis                           1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (49)         (50)         (50)                                   
      Compression                                      3 (6%)       8 (16%)      6 (12%)      5 (10%)                               
      Hemorrhage                                       1 (2%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (49)         (50)         (50)                                   
      Congestion                                       5 (10%)      2 (4%)       5 (10%)      8 (16%)                               
      Foreign Body                                                                            1 (2%)                                
      Infiltration Cellular, Histiocyte               41 (82%)     37 (76%)     39 (78%)     38 (76%)                               
      Inflammation, Chronic                           29 (58%)     33 (67%)     29 (58%)     33 (66%)                               
      Inflammation, Suppurative                                                  1 (2%)                                             
      Necrosis                                                                   1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 1 (2%)       4 (8%)       3 (6%)       2 (4%)                                
   Nose                                               (50)         (49)         (50)         (50)                                   
      Foreign Body                                     4 (8%)       3 (6%)       1 (2%)       3 (6%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Inflammation, Chronic                            8 (16%)      7 (14%)      9 (18%)      6 (12%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (50)         (49)         (50)         (50)                                   
      Cataract                                         1 (2%)       2 (4%)       5 (10%)      3 (6%)                                
      Inflammation, Chronic                                         2 (4%)                                                          
      Anterior Chamber, Inflammation                                             1 (2%)                                             
      Cornea, Inflammation, Chronic                    1 (2%)                    1 (2%)       2 (4%)                                
      Retina, Degeneration                             2 (4%)       2 (4%)       4 (8%)       2 (4%)                                
   Harderian Gland                                    (50)         (49)         (50)         (50)                                   
      Inflammation, Chronic                            3 (6%)       3 (6%)       3 (6%)       4 (8%)                                
      Pigmentation                                     2 (4%)       2 (4%)       1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (49)         (50)         (50)                                   
      Cyst                                                                       1 (2%)       1 (2%)                                
      Infarct                                          1 (2%)                    2 (4%)       2 (4%)                                
      Nephropathy                                     14 (28%)     15 (31%)     21 (42%)     16 (32%)                               
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      6           10            5            7                                     
    Moribund Sacrifice                                13            7            5           10                                     
    Dosing Accident                                                              1            2                                     
  Survivors                                                                                                                         
    Natural Death                                      1                                                                            
    Terminal Sacrifice                                29           33           39           30                                     
    Moribund Sacrifice                                 1                                      1                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (50)         (50)                                   
      Perforation                                                                             2 (4%)                                
   Intestine Large, Colon                             (50)         (50)         (50)         (50)                                   
      Inflammation                                                                            1 (2%)                                
   Intestine Large, Cecum                             (49)         (50)         (49)         (47)                                   
      Inflammation, Chronic                                                                   1 (2%)                                
   Intestine Small, Duodenum                          (50)         (50)         (50)         (48)                                   
      Ectopic Tissue                                   1 (2%)       1 (2%)                                                          
      Ulcer                                                                      1 (2%)                                             
   Intestine Small, Ileum                             (48)         (50)         (49)         (48)                                   
      Hyperplasia, Lymphoid                                                                   1 (2%)                                
   Liver                                              (50)         (50)         (50)         (50)                                   
      Basophilic Focus                                 5 (10%)      6 (12%)      8 (16%)      6 (12%)                               
      Clear Cell Focus                                14 (28%)     13 (26%)     16 (32%)     12 (24%)                               
      Degeneration, Cystic                             5 (10%)      3 (6%)       2 (4%)       1 (2%)                                
      Eosinophilic Focus                               5 (10%)      1 (2%)       4 (8%)       3 (6%)                                
      Hepatodiaphragmatic Nodule                       9 (18%)      2 (4%)       3 (6%)       4 (8%)                                
      Inflammation, Chronic                                         1 (2%)                    1 (2%)                                
      Necrosis, Focal                                  1 (2%)       1 (2%)                                                          
      Bile Duct, Hyperplasia                          41 (82%)     35 (70%)     38 (76%)     37 (74%)                               
      Centrilobular, Necrosis                          2 (4%)                    1 (2%)       2 (4%)                                
      Hepatocyte, Vacuolization Cytoplasmic            5 (10%)      1 (2%)       2 (4%)       3 (6%)                                
      Serosa, Inflammation                                                                    1 (2%)                                
   Mesentery                                          (16)         (11)         (9)          (12)                                   
      Accessory Spleen                                                                        1 (8%)                                
      Fibrosis                                         1 (6%)                                                                       
      Fat, Necrosis                                   14 (88%)      9 (82%)      8 (89%)      7 (58%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Oral Mucosa                                        (1)                                    (4)                                    
      Pharyngeal, Cyst                                                                        2 (50%)                               
      Pharyngeal, Inflammation                                                                2 (50%)                               
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Atrophy                                         43 (86%)     31 (62%)     35 (70%)     32 (64%)                               
      Atrophy, Focal                                                                          1 (2%)                                
      Cyst                                                                                    1 (2%)                                
      Inflammation, Chronic                                                                   1 (2%)                                
      Acinus, Hyperplasia, Focal                       4 (8%)       6 (12%)     15 (30%)     12 (24%)                               
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                                                             1 (2%)                                
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Edema                                            6 (12%)                   1 (2%)       2 (4%)                                
      Erosion                                          3 (6%)                                 1 (2%)                                
      Ulcer                                            4 (8%)       1 (2%)       2 (4%)       2 (4%)                                
      Epithelium, Hyperplasia                          4 (8%)                    3 (6%)       3 (6%)                                
   Stomach, Glandular                                 (50)         (50)         (50)         (50)                                   
      Edema                                            1 (2%)                                 2 (4%)                                
      Erosion                                          4 (8%)       2 (4%)       1 (2%)       1 (2%)                                
      Hyperplasia                                      1 (2%)                                                                       
      Inflammation                                     1 (2%)                                                                       
      Mineralization                                                1 (2%)                                                          
      Ulcer                                            2 (4%)       1 (2%)       2 (4%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  47 (94%)     46 (92%)     47 (94%)     45 (90%)                               
      Mineralization                                                1 (2%)                                                          
      Thrombosis                                                    1 (2%)       1 (2%)                                             
      Pericardium, Inflammation, Granulomatous         1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule               23 (46%)     23 (46%)     28 (56%)     25 (50%)                               
      Degeneration, Fatty                              7 (14%)      6 (12%)      7 (14%)      2 (4%)                                
      Hyperplasia, Focal                               6 (12%)      5 (10%)      5 (10%)      5 (10%)                               
      Hypertrophy, Focal                               6 (12%)      5 (10%)      9 (18%)      8 (16%)                               
      Necrosis                                         1 (2%)                                 1 (2%)                                
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hyperplasia                                      7 (14%)     12 (24%)      8 (16%)      2 (4%)                                
      Thrombosis                                                                 1 (2%)                                             
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                     13 (26%)     13 (26%)     17 (34%)     26 (52%)                               
      Metaplasia, Hepatocyte                                                     1 (2%)                                             
   Pituitary Gland                                    (50)         (50)         (50)         (50)                                   
      Pars Distalis, Angiectasis                      14 (28%)     30 (60%)     16 (32%)     15 (30%)                               
      Pars Distalis, Cyst                              6 (12%)      3 (6%)       6 (12%)      5 (10%)                               
      Pars Distalis, Hyperplasia, Focal                9 (18%)      8 (16%)      9 (18%)     13 (26%)                               
      Pars Distalis, Hyperplasia, Multifocal                        1 (2%)                                                          
      Pars Intermedia, Cyst                            1 (2%)                                                                       
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Ultimobranchial Cyst                             3 (6%)       1 (2%)                    2 (4%)                                
      C-Cell, Hyperplasia                              8 (16%)      2 (4%)       9 (18%)      4 (8%)                                
      Follicle, Cyst                                   1 (2%)       2 (4%)       4 (8%)       1 (2%)                                
      Follicular Cell, Hyperplasia                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Coagulating Gland                                  (1)                       (2)                                                 
      Inflammation                                                               1 (50%)                                            
   Penis                                              (1)                                                                           
      Fibrosis                                         1 (100%)                                                                     
   Preputial Gland                                    (50)         (50)         (50)         (50)                                   
      Cyst                                             4 (8%)                                 3 (6%)                                
      Inflammation, Chronic                            5 (10%)      5 (10%)      4 (8%)       4 (8%)                                
   Prostate                                           (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic                           31 (62%)     28 (56%)     27 (54%)     26 (52%)                               
   Testes                                             (50)         (50)         (50)         (50)                                   
      Bilateral, Germinal Epithelium, Atrophy          1 (2%)                    2 (4%)                                             
      Germinal Epithelium, Atrophy                     1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      7 (14%)      7 (14%)      4 (8%)       9 (18%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Lymph Node                                         (21)         (17)         (10)         (18)                                   
      Deep Cervical, Hyperplasia, Lymphoid                          1 (6%)       1 (10%)                                            
      Deep Cervical, Inflammation, Granulomatous       1 (5%)                                                                       
      Mediastinal, Hyperplasia, Lymphoid               9 (43%)      9 (53%)     10 (100%)    15 (83%)                               
      Mediastinal, Inflammation, Granulomatous         1 (5%)                                                                       
      Pancreatic, Hyperplasia, Lymphoid                2 (10%)      4 (24%)      1 (10%)      1 (6%)                                
   Lymph Node, Mesenteric                             (50)         (50)         (50)         (50)                                   
      Hyperplasia, Lymphoid                            7 (14%)      3 (6%)       4 (8%)       9 (18%)                               
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Fibrosis                                         1 (2%)       2 (4%)       2 (4%)       2 (4%)                                
      Hematopoietic Cell Proliferation                11 (22%)     12 (24%)     17 (34%)     20 (40%)                               
      Hemorrhage                                                                              2 (4%)                                
      Necrosis                                         2 (4%)                                                                       
      Capsule, Fibrosis                                1 (2%)       7 (14%)     12 (24%)     30 (60%)                               
      Lymphoid Follicle, Hyperplasia                                1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)         (50)                                   
      Cyst                                            23 (46%)     18 (36%)     20 (40%)     20 (40%)                               
      Hyperplasia                                      1 (2%)                    1 (2%)                                             
   Skin                                               (50)         (50)         (50)         (50)                                   
      Hyperkeratosis                                                                          1 (2%)                                
      Inflammation, Chronic                                                      5 (10%)      1 (2%)                                
      Lip, Inflammation                                1 (2%)                                                                       
      Subcutaneous Tissue, Mineralization                                                     1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Cyst                                             1 (2%)                                                                       
      Cranium, Osteopetrosis                                        1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Compression                                      7 (14%)     10 (20%)      9 (18%)      6 (12%)                               
      Hemorrhage                                       1 (2%)       2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                       3 (6%)       4 (8%)       3 (6%)       7 (14%)                               
      Foreign Body                                                               1 (2%)       2 (4%)                                
      Hemorrhage                                       1 (2%)                                                                       
      Infiltration Cellular, Histiocyte               28 (56%)     29 (58%)     36 (72%)     26 (52%)                               
      Inflammation, Chronic                           29 (58%)     23 (46%)     36 (72%)     30 (60%)                               
      Inflammation, Suppurative                                                               1 (2%)                                
      Necrosis                                                                   1 (2%)       1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 7 (14%)      9 (18%)      4 (8%)       6 (12%)                               
      Mediastinum, Inflammation, Granulomatous         1 (2%)                                                                       
   Nose                                               (50)         (50)         (50)         (50)                                   
      Foreign Body                                     7 (14%)      4 (8%)      12 (24%)      7 (14%)                               
      Inflammation, Chronic                           12 (24%)      3 (6%)      20 (40%)     15 (30%)                               
   Pleura                                             (1)                                                                           
      Inflammation, Granulomatous                      1 (100%)                                                                     
   Trachea                                            (50)         (50)         (50)         (50)                                   
      Foreign Body                                                                            1 (2%)                                
      Inflammation                                     1 (2%)                    1 (2%)                                             
      Necrosis                                                                                1 (2%)                                
      Perforation                                                                1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (50)         (49)         (48)         (48)                                   
      Cataract                                         1 (2%)       3 (6%)       4 (8%)       3 (6%)                                
      Inflammation, Chronic                            1 (2%)                    1 (2%)       1 (2%)                                
      Phthisis Bulbi                                                                          1 (2%)                                
      Anterior Chamber, Inflammation, Acute                                                   1 (2%)                                
      Bilateral, Anterior Chamber, Inflammation,                                                                                    
         Acute                                                      1 (2%)                                                          
      Retina, Degeneration                             1 (2%)       2 (4%)       4 (8%)       3 (6%)                                
   Harderian Gland                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                                                1 (2%)       1 (2%)                                
      Inflammation, Chronic                            2 (4%)       3 (6%)       1 (2%)       4 (8%)                                
      Pigmentation                                     2 (4%)       1 (2%)       1 (2%)       3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Cyst                                                                       1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 91005-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                     METHYLENE BLUE TRIHYDRATE                                 Date: 03/25/05    
Route: GAVAGE                                                                                                     Time: 10:00:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/KG      5 MG/KG      25 MG/KG     50 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Hydronephrosis                                                1 (2%)                    2 (4%)                                
      Infarct                                          2 (4%)                                                                       
      Nephropathy                                     35 (70%)     39 (78%)     33 (66%)     34 (68%)                               
   Urethra                                                                                   (1)                                    
      Inflammation                                                                            1 (100%)                              
   Urinary Bladder                                    (50)         (50)         (50)         (49)                                   
      Hemorrhage                                       1 (2%)                                 1 (2%)                                
      Hyperplasia                                                                1 (2%)                                             
      Inflammation, Chronic                                         2 (4%)                    1 (2%)                                
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------